Pfizer Choosing Site for $200M Expansion

Source: BioSpace

Feb 12, 2016

Pfizer is considering an expansion in one of three locations -- Andover, Massachusetts; Grange Castle, Ireland; or Chesterfield, Missouri.

Andover is lobbying hard, attempting to work out a possible Tax Increment Financing (TIF) plan to entice the Pfizer to expand in the area.

The Andover space is currently a 70-acre site that combines state-of-the-art R&D facilities with flexible, multi-product manufacturing capabilities. The campus consists of eight buildings which house laboratories, clinical and commercial manufacturing suites, purification and support areas and a clinical Drug Product manufacturing facility.

If the project goes through in Andover, Pfizer anticipates spending $200 million overall, with $50 million for machinery and equipment expansion, and the rest for construction. Pfizer’s expanded presence would also potentially mean 200 more job opportunities.

Read the BioSpace story

Show Comments
Hide Comments

Join the discussion

We welcome your thoughtful comments.
All comments will display your user name.

Want to participate in the discussion?

Register for free

Log in for complete access.


No one has commented on this page yet.

RSS feed for comments on this page | RSS feed for all comments